A 52-year-old man with hypertension presents with palpitations and dyspnea. On examination, an irregular pulse is noted. A 12-lead ECG shows absence of P waves and an irregularly irregular rhythm with a ventricular rate of 110 bpm. Which investigation is most appropriate to assess the structural substrate and guide long-term management?

Question

Accepted Answer

A. Transthoracic echocardiography. ## Clinical Context

The ECG findings — absent P waves, irregularly irregular rhythm, and rapid ventricular response — are diagnostic of atrial fibrillation (AF). The clinical question shifts from diagnosis (already established by ECG) to assessment of the structural heart and risk stratification.

## Why Transthoracic Echocardiography Is Correct

**Key Point:** Transthoracic echocardiography (TTE) is the first-line imaging modality in newly diagnosed AF to:
- Assess left ventricular function (ejection fraction, wall motion)
- Evaluate left atrial size and function
- Detect underlying structural heart disease (valvular disease, cardiomyopathy, LV hypertrophy)
- Screen for thrombus in the left atrial appendage (LAA)
- Guide anticoagulation and rate-control strategy

**High-Yield:** TTE is recommended by ACC/AHA guidelines as part of the initial evaluation of all patients with newly diagnosed AF to identify reversible causes and stratify stroke/heart failure risk.

**Clinical Pearl:** In this patient with hypertension and new-onset AF, TTE will likely show left ventricular hypertrophy and possibly impaired diastolic function — common substrates for hypertension-related AF.

## Why Other Options Are Incorrect

| Investigation | Timing / Indication |
| --- | --- |
| **Cardiac MRI** | Reserved for specific indications: suspected infiltrative/inflammatory disease, arrhythmogenic right ventricular cardiomyopathy, or when TTE is inconclusive. Not first-line for routine AF evaluation. |
| **Coronary angiography** | Indicated only if the patient has symptoms or signs of acute coronary syndrome, or if non-invasive stress testing is abnormal. Not part of routine AF workup unless ischemia is suspected. |
| **Electrophysiology study** | Performed for rhythm control strategy (ablation) after medical therapy failure, or for specific arrhythmia mapping. Not indicated for initial structural assessment in newly diagnosed AF. |

## Investigation Algorithm for New-Onset AF

```mermaid
flowchart TD
  A[New-onset Atrial Fibrillation]:::outcome --> B[12-lead ECG]:::action
  B --> C[Diagnosis confirmed]:::outcome
  C --> D[Transthoracic Echocardiography]:::action
  D --> E{Structural disease detected?}:::decision
  E -->|Yes: HF, valvular disease| F[Optimize medical therapy]:::action
  E -->|No: structurally normal| G[Assess stroke risk - CHA₂DS₂-VASc]:::action
  G --> H[Anticoagulation + Rate control]:::action
  H --> I{Symptom control achieved?}:::decision
  I -->|No| J[Consider rhythm control / Ablation]:::action
  I -->|Yes| K[Long-term follow-up]:::outcome
```

![ECG — Waves and Intervals diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3603.webp)

Answer

B. Coronary angiography

Answer

C. Electrophysiology study with intracardiac mapping

Answer

D. Cardiac MRI with late gadolinium enhancement

Explanation

Clinical Context

Why Transthoracic Echocardiography Is Correct

Why Other Options Are Incorrect

Investigation Algorithm for New-Onset AF

Practice similar questions

Join our NEET PG community

Investigation	Timing / Indication
Cardiac MRI	Reserved for specific indications: suspected infiltrative/inflammatory disease, arrhythmogenic right ventricular cardiomyopathy, or when TTE is inconclusive. Not first-line for routine AF evaluation.
Coronary angiography	Indicated only if the patient has symptoms or signs of acute coronary syndrome, or if non-invasive stress testing is abnormal. Not part of routine AF workup unless ischemia is suspected.
Electrophysiology study	Performed for rhythm control strategy (ablation) after medical therapy failure, or for specific arrhythmia mapping. Not indicated for initial structural assessment in newly diagnosed AF.